<?xml version="1.0"?>

<document>
	<title>The use of new antibiotic agents for chronic pulmonary disease.</title>

	<author>Huang-N-N.</author>

	<source>Pediatr-Ann. 1978 Jan. 7(1). P 56, 58-60, 62 passim.</source>

	<abstract>Modern advances in the development of antimicrobial agents and in
   chemotherapy have made available potent aminoglycoside antibiotics,
   with more effective ones to come. Their effectiveness against P.
   aeruginosa is a great contribution to patients with cystic fibrosis
   and other chronic disorders. The development of carbenicillin has
   augmented the effectiveness of the aminoglycoside antibiotics.
   Ticarcillin is similar to carbenicillin and will play a similar role
   in antibiotic therapy. The cephalosporins serve as alternative agents
   principally for their antistaphylococcal activity. We are urgently in
   need of a potent antibiotic agent against P. aeruginosa that can be
   given by the oral route. The TMP-SMX combination is a potent
   chemotherapeutic agent that can be administered by the oral route. It
   is effective in the treatment of P. carinii pneumonia, which is very
   common owing to the extended survival of patients with leukemia and
   other malignancies or with allografts who are prone to develop
   infections with immunosuppressive therapy.</abstract>

	<majorsubject>ANTIBIOTICS: tu</majorsubject>
	<majorsubject>BACTERIAL-INFECTIONS: dt</majorsubject>
	<majorsubject>RESPIRATORY-TRACT-INFECTIONS: dt</majorsubject>

	<minorsubject>AGAMMAGLOBULINEMIA: co</minorsubject>
	<minorsubject>AMINOGLYCOSIDES: tu</minorsubject>
	<minorsubject>ASTHMA: co</minorsubject>
	<minorsubject>CEPHALOSPORINS: tu</minorsubject>
	<minorsubject>CHRONIC-DISEASE</minorsubject>
	<minorsubject>CYSTIC-FIBROSIS: co</minorsubject>
	<minorsubject>IMMUNOLOGIC-DEFICIENCY-SYNDROMES: co</minorsubject>
	<minorsubject>PENICILLINS: tu</minorsubject>
	<minorsubject>PNEUMONIA-ASPIRATION: co</minorsubject>
	<minorsubject>RESPIRATORY-TRACT-INFECTIONS: et</minorsubject>
	<minorsubject>SULFAMETHOXAZOLE: tu</minorsubject>
	<minorsubject>TETRACYCLINES: tu</minorsubject>
	<minorsubject>TRIMETHOPRIM: tu</minorsubject>

	<reference>001   WOOD RE               AM REV RESPIR DIS              113   833 976</reference>
	<reference>002   CUMMING WA            RADIOLOGY                      105   387 972</reference>
	<reference>003   BARTLETT JG           CHEST                           68   560 975</reference>
	<reference>004   KIM IG                LARYNGOSCOPE                    83   347 973</reference>
	<reference>005   GOSINK BB             AM J ROENTG RAD THER NUCL MED  117   816 973</reference>
	<reference>006   LARAYA-CUASAY LR      AM REV RESPIR DIS              109   703 974</reference>
	<reference>007   BAUER AW              AM J CLIN PATHOL                45   493 966</reference>
	<reference>008   STRATFORD BC          LANCET                           1   378 974</reference>
	<reference>009   MENDELSON J           ANTIMICROB AGENTS CHEMOTHER      9   633 976</reference>
	<reference>010   MEYERS RM             ARCH OTOLARYNGOL                92   160 970</reference>
	<reference>011   KOSSEK JC             J LAB INVEST                    30    48 974</reference>
	<reference>012   BOBROW SN             JAMA                           222  1546 972</reference>
	<reference>013   HOLMES RK             ANTIMICROB AGENTS CHEMOTHER      6   253 974</reference>
	<reference>014   HOUANG ET             LANCET                           1   423 976</reference>
	<reference>015   NEU HC                J INFECT DIS SUPPL             134     3 976</reference>
	<reference>016   HUANG NN              INFECTION SUPPL                  4   465 976</reference>
	<reference>017   MARKS MI              J CLIN PHARMACOL                15   246 975</reference>
	<reference>018   HUANG NN              CLINICAL EXPERIENCE WITH AMIK            976</reference>
	<reference>019   KHAN AJ               CURR THER RES                   19   479 976</reference>
	<reference>020   KLASTERSKY J          J MED MICROBIOL                  7   465 974</reference>
	<reference>021   LEVISON ME            ANTIMICROB AGENTS CHEMOTHER      5   667 974</reference>
	<reference>022   MCLAUGHLIN JE         LANCET                           1   261 971</reference>
	<reference>023   RIFF LJ               ARCH INTERN MED                130   887 972</reference>
	<reference>024   LEVINE BB             J INFECT DIS SUPPL             128   364 973</reference>
	<reference>025   TUANO SB              ANTIMICROB AGENTS CHEMOTHER      6   101 966</reference>
	<reference>026   BURTON JR             JAMA                           229   679 974</reference>
	<reference>027   THORNHILL TS          APPL MICROBIOL                  17   457 969</reference>
	<reference>028   STORE SD              J POSTGRAD MED                  21   121 975</reference>
	<reference>029   KIRBY WMM             J INFECT DIS SUPPL             128   341 973</reference>
	<reference>030   STANFORD HC           J INFECT DIS SUPPL             122     9 970</reference>
	<reference>031   HUANG NN              J PEDIATR                       78   338 971</reference>
	<reference>032   BROWN CH 3RD          N ENGL J MED                   291   265 974</reference>
	<reference>033   ERVIN ER              ANTIMICROB AGENTS CHEMOTHER      9    94 976</reference>
	<reference>034   PARRY MF              J PEDIATR                       90   144 977</reference>
	<reference>035   PARRY MF              J INFECT DIS SUPPL             134   194 976</reference>
	<reference>036   NEU HC                ANTIMICROB AGENTS CHEMOTHER      8   457 975</reference>
	<reference>037   HUANG NN              ANTIMICROB AGENTS CHEMOTHER      6   127 966</reference>
	<reference>038   PINES A               PRACTITIONER                   213   727 974</reference>
	<reference>039   BROGDEN RN            DRUGS                            9   251 975</reference>
	<reference>040   GROSSMAN ER           PEDIATRICS                      47   567 971</reference>
	<reference>041   FRIMPTER GW           JAMA                           184   111 963</reference>
	<reference>042   KABU SB               CLIN PHARMACOL THER              9   550 968</reference>
	<reference>043   BERGAN T              ACTA MED SCAND                 192   483 972</reference>
	<reference>044   LEWIN EB              J INFECT DIS SUPPL             128   618 973</reference>
	<reference>045   STORE SD              J POSTGRAD MED                  21   114 975</reference>
	<reference>046   KNIGHT D              LANCET                           2   717 975</reference>
	<reference>047   HUGHES WT             CANCER                          36  2004 975</reference>
	<reference>048   HUGHES WT             N ENGL J MED                   295   726 976</reference>


</document>
